Part,  Chapter, Paragraph

  1    I,     2.  6        |         and EFTA countries.~ ~The indicator shows the percentage of
  2    I,     2.  6        |          secondary education. The indicator aims at measuring the share
  3    I,     3.  1        |          fertility rate (TFR = an indicator corresponding to the mean
  4   II,     4.Acr        |        Global Activity Limitation Indicator~HLY~Healthy Life Years~LE~
  5   II,     4.  1        |         HLY), a health expectancy indicator among the Structural Indicators.
  6   II,     4.  1        |           the first EU Structural Indicator on health and in its 2005
  7   II,     4.  1        |  reporting one’s own health, this indicator is likely to be more appropriate
  8   II,     4.  1        |           the HLY as a Structural Indicator, using survey data coming
  9   II,     4.  1        |      prosperity. Thus, HLY as the indicator to monitor health within
 10   II,     4.  3        |        Global Activity Limitation Indicator (GALI): Sozial- und Präventivmedizin
 11   II,     5.  2.  3    |           most valid and reliable indicator. According to the MONICA
 12   II,     5.  3.Acr    |   EUROCHIP~European Cancer Health Indicator Project~FACT~Fighting Against
 13   II,     5.  3.  1    |        population and is a useful indicator for planning and allocation
 14   II,     5.  3.  3    |           for men and women. This indicator is available for selected
 15   II,     5.  4.  2    |       OECD indicators~ ~ ~Areas~ ~Indicator Name~Processes of diabetes
 16   II,     5.  4.  2    |          over 20 countries~ ~Core indicator~ ~Countries with recent
 17   II,     5.  4.  2    |  Prevalence over 25 yrs, an EUCID indicator, is very similar to the
 18   II,     5.  4.  2    |           the percentage for this indicator varied from 2% (Turkey)
 19   II,     5.  4.  2    |          most fundamental outcome indicator of all, through which countries
 20   II,     5.  4.  2    |          of health policies. This indicator is defined as the annual
 21   II,     5.  4.  2    |       over 20 countries~Secondary indicator~ ~Countries with~recent
 22   II,     5.  4.  2    |         Level of HbA1c>7.0% is an indicator of poor management causing
 23   II,     5.  4.  2    |         of HbA1c above 7.0%. This indicator is also measured by OECD,
 24   II,     5.  4.  2    |          5 mmol/l is an important indicator of lipidic control that
 25   II,     5.  4.  2    |          6 mmol/l is an important indicator of lipidic control that
 26   II,     5.  4.  2    |        months is also taken as an indicator for lipids, measured by
 27   II,     5.  4.  2    |          3 mmol/l is an important indicator of lipidic control that
 28   II,     5.  4.  2    |           The clinical management indicator is defined as the percentage
 29   II,     5.  4.  2    |         is an extremely difficult indicator to collect, unless there
 30   II,     5.  4.  2    |        complications. The process indicator is measured by the percentage
 31   II,     5.  4.  2    |           in last 12 months. This indicator is the only one reported
 32   II,     5.  4.  2    |        proliferative retinopathy.~Indicator on timely laser treatment
 33   II,     5.  4.  3    |           the percentage for this indicator varied from 2% (Turkey)
 34   II,     5.  4.  3    |       median of 79 (Denmark). The indicator decreases before the age
 35   II,     5.  4.  3    |         last 12 months. The EUCID indicator varies between countries
 36   II,     5.  4.  3    |         last 12 months. The EUCID indicator varies in 11 countries between
 37   II,     5.  4.  3    |       ranging between 1% and 14%.~Indicator on timely laser treatment
 38   II,     5.  4.  3    |          of retinopathy. For this indicator, data is even more scarce
 39   II,     5.  4.  3    |           major amputations. This indicator, measured by EUCID across
 40   II,     5.  4.  3    |           influence of age on the indicator: the older the individual,
 41   II,     5.  4.  3    |        median equal to 654.5. The indicator is age dependant with a
 42   II,     5.  4.  6    |            the “European Diabetes Indicator Project” (EUDIP) has provided
 43   II,     5.  5.  3    |           has been shown to be an indicator for a more severe disease
 44   II,     5.  9.  5    |       asthma related deaths as an indicator of the quality of ambulatory
 45   II,     7.  3.  2    |          the most frequently used indicator for injuries and has a high
 46   II,     7.  4        |         European Community Health Indicator system (ECHI) is a proposal
 47   II,     7.  7        |        discharge database (2008): Indicator 494 - Number of eligible
 48   II,     8.  1.  2    |        last 6 months or more. The indicator used is the percentage prevalence
 49   II,     8.  2.  1    |   participation and also as a key indicator of quality of life (AAMR,
 50   II,     9            |    mothers and children and is an indicator of effective antenatal preventive
 51   II,     9.  1.  1    |      rates between countries.~ ~ ~Indicator~Definition~Points to consider
 52   II,     9.  1.  1    |        charged with developing an indicator set for monitoring and describing
 53   II,     9.  1.  1    |           resulting EURO-PERISTAT indicator set reflects a solid base
 54   II,     9.  1.  1    |        breast-feeding at birth~F: Indicator of support to women~F: Indicator
 55   II,     9.  1.  1    |  Indicator of support to women~F: Indicator of maternal satisfaction~
 56   II,     9.  1.  1    |    Monitoring~CP is a recommended indicator by EURO-PERISTAT for long-term
 57   II,     9.  1.  1    |           al (2003): Selecting an indicator set for monitoring and evaluating
 58   II,     9.  1.  2    |    mothers and children and is an indicator of effective antenatal preventive
 59   II,     9.  2.  2    |        opportunity can be a prime indicator: across all Member States
 60   II,     9.  3.  2    |     Mortality~ ~The EURO-PERISTAT indicator list includes one core indicator
 61   II,     9.  3.  2    |  indicator list includes one core indicator for monitoring maternal
 62   II,     9.  3.  2    |         EURO-PERISTAT recommended indicator, but this indicator is still
 63   II,     9.  3.  2    |   recommended indicator, but this indicator is still being developed
 64   II,     9.  3.  2    |     feasibility and quality of an indicator based on a set of conditions
 65   II,     9.  3.  2    |     hospital discharge data. This indicator is determined by the number
 66   II,     9.  3.  2    |           1a.~ ~The EURO-PERISTAT indicator set specified several key
 67   II,     9.  3.  2    |           was also targeted as an indicator for further development
 68   II,     9.  3.  2    |           al (2003): Selecting an indicator set for monitoring and evaluating
 69   II,     9.  3.  3    |         at a very young age is an indicator of a higher probability
 70  III,    10.  2.  1    |       whereby the education is an indicator of the socio-economic status.
 71  III,    10.  2.  1    |    Addiction~TDI~Treatment demand indicator~ ~ ~
 72  III,    10.  2.  1    |        and can thus be used as an indicator of problem drug use. The
 73  III,    10.  2.  1    |          use is also an important indicator to understand the characteristics
 74  III,    10.  2.  1    |           in the Treatment Demand Indicator (TDI) data set, while the
 75  III,    10.  2.  1(17)|           about ‘Treatment Demand Indicatorplease visit http ds~
 76  III,    10.  2.  2    |        incidence, which is a good indicator of the magnitude of the
 77  III,    10.  2.  5    |         European Community Health Indicator (ECHI) long list includes
 78  III,    10.  2.  5    |            long list includes the indicatorPregnant women smoking”,
 79  III,    10.  3.  1    |      period of 8 hours. The noise indicator for the night time period,
 80  III,    10.  3.  2    | decreasing. Breast milk is a good indicator of human exposure to persistent
 81  III,    10.  3.  2    |           is regularly used as an indicator of exposure. The bio-monitoring
 82  III,    10.  4.  1    |        respiratory symptoms. This indicator is also well correlated
 83  III,    10.  4.  2    |            Non dioxin-like PCBs~(‘indicatorPCBs)~ ~Oils and fats of
 84  III,    10.  4.  2    |          standards for the seven~‘indicatorPCBs; EU: risk~assessment
 85  III,    10.  4.  5    |        assessment of the core set indicatorProgress in management
 86  III,    10.  4.  5    |        assessment of the core set indicatorProgress in management
 87  III,    10.  5.  1    |          cities with data on this indicator).~ ~
 88  III,    10.  5.  1    |      city-level data is merely an indicator to monitor the general trends
 89  III,    10.  5.  1    |    development of an urban health indicator system as an essential part
 90  III,    10.  6.  1    |           1.2.1 The Mental health indicator pilot study~This pilot study,
 91  III,    10.  6.  1    |    parents is considered to be an indicator of social support from parents
 92   IV,    11.  1.  3    |       concept might be used as an indicator for health system performance
 93   IV,    11.  1.  3    |        sought to develop a single indicator of performance. However,
 94   IV,    11.  1.  3    |          Furthermore, a composite indicator compounds the inaccuracy
 95   IV,    11.  1.  4    |      Although health status as an indicator of need is the most commonly
 96   IV,    11.  1.  4    |         is the most commonly used indicator -,mainly because it can
 97   IV,    11.  1.  5    |          evaluation of the Danish indicator project established in 2000
 98   IV,    11.  1.  5    |           the Health Care Quality Indicator Project to track quality
 99   IV,    11.  1.  5    |        domains (and a fifth bonus indicator on 'access'). The four domains
100   IV,    11.  1.  5    |         additional services. Each indicator is weighed, contributing
101   IV,    11.  6.  5    |   indicators: the Danish National Indicator Project." International
102   IV,    11.  6.  5    |            Quality evaluation and indicator comparison in health care."
103   IV,    12.  5        |    Healthy Life Yearsstructural indicator, submitted every year to
104   IV,    12.  5        |            as European Structural Indicator~ ~Prior to acceptance as
105   IV,    12.  5        |       acceptance as EU Structural Indicator, HLY underwent a rigorous
106   IV,    12.  5        |     assessment to be a Structural Indicator, HLY was awarded a grade
107   IV,    12.  5        |        Especially in the field of indicator development an important
108   IV,    12. 10        |      Genomics and public healh~No indicator~ ~ ~Hypertension~No indicator~ ~
109   IV,    12. 10        |     indicator~ ~ ~Hypertension~No indicator~ ~Interactions amongst determinants~
110   IV,    12. 10        |           amongst determinants~No indicator~ ~ ~ ~ ~B) Actions adopted
111   IV,    13.  2.  3    |         been modeled using BMI as indicator. Overweight can also be